4L4-16539-47000
5 vaccinations
4 coded responses
45 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 770 / TX
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-24
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
-
2021-01-29
Survey response — day 21, dose 2MedDRA: Arthralgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Pain, off and on, in left ankle. It happened for a few days after the 1st dose, but I didn't make the connection until it returned after the 2nd dose. It's now been present about 1 weekMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-10-02
Dose 3 — Pfizer-BioNTech
-
2022-01-08
Survey response — 12 months, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Severe asthma exacerbation that lasted 10 weeks despite maximal therapy, including systemic and inhaled steroids, inhaled tiotropium bromide, and inhaled albuterolMedDRA releases: 2024-11 · check-in free text available
-
2022-01-08
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-10
-
2022-01-13
Call successfulDoes not wish to fill out VAERS report
-
2022-04-21
Dose 4 — Pfizer-BioNTech
- 2022-04-21
-
2022-04-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-04-23
-
2022-04-24
Survey response — days 1–6 daily, dose 4MedDRA: Axillary pain — Feeling: Good · Site: PainFree text: Pain in axilla of arm where shot receivedMedDRA releases: 2024-11 · check-in free text available
- 2022-04-25
- 2022-04-26
- 2022-04-27
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-05-19
- 2022-05-26
- 2022-06-02
- 2022-07-21
-
2022-09-30
Dose 5 — Pfizer-BioNTech
- 2022-10-16
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-11
-
2022-12-30
Survey response — 3 months, dose 5MedDRA: Dyspnoea, Nasal congestion, Wheezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Shortness of breath, wheezing, nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-04-21 | Pfizer-BioNTech | No |
| 5 | 2022-09-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 3 — day 21, dose 2
Symptoms: Pain, off and on, in left ankle. It happened for a few days after the 1st dose, but I didn't make the connection until it returned after the 2nd dose. It's now been present about 1 week
Release 10 — 12 months, dose 2
Symptoms: Severe asthma exacerbation that lasted 10 weeks despite maximal therapy, including systemic and inhaled steroids, inhaled tiotropium bromide, and inhaled albuterol
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Pain in axilla of arm where shot received
Release 12 — 3 months, dose 5
Symptoms: Shortness of breath, wheezing, nasal congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release